These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 20570389)
1. Prognostic value of xanthine oxidoreductase expression in patients with non-small cell lung cancer. Kim AW; Batus M; Myint R; Fidler MJ; Basu S; Bonomi P; Faber LP; Wightman SC; Warren WH; McIntire M; Arvanitis LD; Gattuso P; Xu X; Liptay MJ Lung Cancer; 2011 Feb; 71(2):186-90. PubMed ID: 20570389 [TBL] [Abstract][Full Text] [Related]
2. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780 [TBL] [Abstract][Full Text] [Related]
3. Decreased xanthine oxidoreductase (XOR) is associated with a worse prognosis in patients with serous ovarian carcinoma. Linder N; Bützow R; Lassus H; Lundin M; Lundin J Gynecol Oncol; 2012 Feb; 124(2):311-8. PubMed ID: 22044687 [TBL] [Abstract][Full Text] [Related]
4. Cell cycle regulators and outcome of adjuvant cisplatin-based chemotherapy in completely resected non-small-cell lung cancer: the International Adjuvant Lung Cancer Trial Biologic Program. Filipits M; Pirker R; Dunant A; Lantuejoul S; Schmid K; Huynh A; Haddad V; André F; Stahel R; Pignon JP; Soria JC; Popper HH; Le Chevalier T; Brambilla E J Clin Oncol; 2007 Jul; 25(19):2735-40. PubMed ID: 17602078 [TBL] [Abstract][Full Text] [Related]
5. Predictive value of thymidylate synthase and dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (tegafur+uracil) in patients with non-small cell lung cancer. Miyoshi T; Kondo K; Toba H; Yoshida M; Fujino H; Kenzaki K; Sakiyama S; Takehisa M; Tangoku A Anticancer Res; 2007; 27(4C):2641-8. PubMed ID: 17695427 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients. Chen P; Li J; Ge LP; Dai CH; Li XQ Respirology; 2010 Apr; 15(3):501-9. PubMed ID: 20210890 [TBL] [Abstract][Full Text] [Related]
7. Expression of ERCC1 and class III beta-tubulin in non-small cell lung cancer patients treated with carboplatin and paclitaxel. Azuma K; Sasada T; Kawahara A; Takamori S; Hattori S; Ikeda J; Itoh K; Yamada A; Kage M; Kuwano M; Aizawa H Lung Cancer; 2009 Jun; 64(3):326-33. PubMed ID: 18977553 [TBL] [Abstract][Full Text] [Related]
8. [Prognostic analysis of stage III-IV non-small cell lung cancer patients treated by traditional chinese medicine]. Zhou DH; Lin LZ; Zhou YQ; Luo RC; Liu KF; Jia YJ; Chen JY; Niu XW; Su BR; Lu J; Wang ST Ai Zheng; 2005 Oct; 24(10):1252-6. PubMed ID: 16219143 [TBL] [Abstract][Full Text] [Related]
9. Influence of smoking on histologic type and the efficacy of adjuvant chemotherapy in resected non-small cell lung cancer. Zhang Z; Xu F; Wang S; Li N; Wang C Lung Cancer; 2008 Jun; 60(3):434-40. PubMed ID: 18036699 [TBL] [Abstract][Full Text] [Related]
10. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone. Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805 [TBL] [Abstract][Full Text] [Related]
11. Xanthine oxidoreductase - clinical significance in colorectal cancer and in vitro expression of the protein in human colon cancer cells. Linder N; Martelin E; Lundin M; Louhimo J; Nordling S; Haglund C; Lundin J Eur J Cancer; 2009 Mar; 45(4):648-55. PubMed ID: 19112016 [TBL] [Abstract][Full Text] [Related]
12. [Study of prognostic factors in patients with stage I non-small cell lung cancer]. Jiang ZQ; Jiang GL; Shi DR; Zhang RX; Fu XL; Qian H Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):364-8. PubMed ID: 15312349 [TBL] [Abstract][Full Text] [Related]
13. [Prognosis after complete surgical resection for non-small cell lung cancer based on the staging classification]. Pfannschmidt J; Muley T; Hoffmann H; Bülzebruck H; Dienemann H Dtsch Med Wochenschr; 2006 Nov; 131(47):2643-8. PubMed ID: 17109272 [TBL] [Abstract][Full Text] [Related]
14. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer]. Huang PY; Liang XM; Lin SX; Luo RZ; Hou JH; Zhang L Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926 [TBL] [Abstract][Full Text] [Related]
15. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy. Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636 [TBL] [Abstract][Full Text] [Related]
16. [Predicting efficacy of neoadjuvant cheomotherapy on resectable stage IIIA non-small cell lung cancer by multi-gene expressions]. Cheng C; Wu YL; Gu LJ; Chen G; Weng YM; Feng WN; Zhong WZ Ai Zheng; 2005 Jul; 24(7):846-9. PubMed ID: 16004813 [TBL] [Abstract][Full Text] [Related]
17. Predictive value of dihydropyrimidine dehydrogenase expression in tumor tissue, regarding the efficacy of postoperatively administered UFT (Tegafur + Uracil) in patients with p-stage I nonsmall-cell lung cancer. Nakagawa T; Tanaka F; Takata T; Matsuoka K; Miyahara R; Otake Y; Yanagihara K; Fukushimab M; Wada H J Surg Oncol; 2002 Oct; 81(2):87-92. PubMed ID: 12355409 [TBL] [Abstract][Full Text] [Related]
18. [Two patterns of mediastinal lymph node resection for non-small cell lung cancer of stage IIIA: survival analysis of 219 cases]. Zhang GQ; Han F; Gao SL; A DL; Pang ZL Ai Zheng; 2007 May; 26(5):519-23. PubMed ID: 17672944 [TBL] [Abstract][Full Text] [Related]
19. Down-regulated xanthine oxidoreductase is a feature of aggressive breast cancer. Linder N; Lundin J; Isola J; Lundin M; Raivio KO; Joensuu H Clin Cancer Res; 2005 Jun; 11(12):4372-81. PubMed ID: 15958620 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer. Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]